Brucato Antonio Luca

Duration of Disease and Long‐Term Outcomes in Patients With Difficult‐To‐Treat Recurrent Pericarditis: A Chronic Condition Treated With Nonsteroidal Anti‐Inflammatory Drugs, Colchicine, Corticosteroids, and Anti–Interleukin‐1 Agents / E. Ceriani, F. Agozzino, S. Berra, A. Gidaro, P. Bindi, A. Pavarani, S. Macchi, L. Vena, F. Moda, L.L. Sicignano, C.A. Murace, L. Gerardino, E. Verrecchia, C.C. De Carlini, S. Maestroni, G. Marinaro, E. Bizzi, A. Brucato, M. Imazio. - In: ACR OPEN RHEUMATOLOGY. - ISSN 2578-5745. - 7:1(2025 Jan), pp. e11776.1-e11776.10. [10.1002/acr2.11776]

Old and New Biomarkers in Idiopathic Recurrent Acute Pericarditis (IRAP): Prognosis and Outcomes / R. Mascolo, E. Bizzi, M. Martelli, C. Facoetti, G. Colazzo, F. Barone, A. Brucato. - In: CURRENT CARDIOLOGY REPORTS. - ISSN 1523-3782. - 27:1(2025), pp. 17.1-17.12. [10.1007/s11886-024-02170-y]

Decrease in Hemoglobin Levels during Acute Attacks in Patients with Idiopathic Recurrent Pericarditis: A Model of Anemia in Acute Disease / F. Casarin, R. Mascolo, I. Motta, M.A. Wu, E. Bizzi, A. Pedroli, G. Dieguez, G. Iacomelli, L. Serati, L. Duca, S. Maestroni, E. Tombetti, M.D. Cappellini, A. Brucato. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 13:19(2024 Oct 06), pp. 5944.1-5944.11. [10.3390/jcm13195944]

Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From the RHAPSODY Long-term Extension / A. Brucato, L. Trotta, M. Arad, P.C. Cremer, A. Insalaco, M. Klutstein, M. Lewinter, D. Lin, S.A. Luis, Y. Wasserstrum, J. Clair, S. Wang, A.L. Klein, M. Imazio, J.F. Paolini. - In: CJC OPEN. - ISSN 2589-790X. - 6:6(2024 Jun), pp. 805-810. [10.1016/j.cjco.2024.02.002]

Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries / A. Vitale, V. Caggiano, A. Tufan, G. Ragab, E.D. Batu, P. Portincasa, E. Aragona, J. Sota, G. Conti, A. De Paulis, D. Rigante, A.N. Olivieri, A. Şahin, F. La Torre, G. Lopalco, M. Cattalini, M.C. Maggio, A. Insalaco, P.P. Sfikakis, E. Verrecchia, D. Yildirim, H. Kucuk, R.C. Kardas, A.H. Laymouna, M. Ghanema, M.A. Saad, S. Sener, H. Ercan Emreol, S. Ozen, N. Jaber, M. Khalil, A. Di Ciaula, C. Gaggiano, G. Malizia, A. Affronti, S. Patroniti, M. Romeo, J. Sbalchiero, F. Della Casa, I. Mormile, S. Silvaroli, M.F. Gicchino, N.Ç. Çelik, M. Tarsia, A. Karamanakos, J. Hernández-Rodríguez, P. Parronchi, D. Opris-Belinski, P. Barone, A. Recke, S. Costi, P. Sfriso, H.A.M. Giardini, S. Gentileschi, E. Wiesik-Szewczyk, I. Vasi, R. Loconte, K. Jahnz-Różyk, E. Martín-Nares, J. Torres-Ruiz, A. Cauli, A. Conforti, G. Emmi, F. Li Gobbi, G.R. Biasi, R. Terribili, P. Ruscitti, E. Del Giudice, S. Tharwat, A.L. Brucato, B. Ogunjimi, A. Hinojosa-Azaola, A. Balistreri, C. Fabiani, B. Frediani, L. Cantarini. - In: FRONTIERS IN IMMUNOLOGY. - ISSN 1664-3224. - 15:(2024 May 10), pp. 1397890.1-1397890.12. [10.3389/fimmu.2024.1397890]